| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/01/2004 | CN1164264C Notoginseng general saponin dispersed tablet and its preparation method |
| 08/31/2004 | US6784310 Crystals of the compound can be obtained in a stable manner with good workability avoiding an oil formation and scaling and with a large mean crystal particle diameter and good powder characteristics |
| 08/31/2004 | US6784291 Splice-region antisense composition and method |
| 08/31/2004 | US6784205 Compounds that modulate the activity of PTP-1B and TC-PTP |
| 08/31/2004 | US6784202 Cubane derivatives as metabotropic glutamate receptor agonists or antagonists and process for their preparation |
| 08/31/2004 | US6784198 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/31/2004 | US6784197 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/31/2004 | US6784195 Extracellular signal regulated kinase (erk); anticancer agents and protein kinase inhibitors |
| 08/31/2004 | US6784192 Na+ channel inhibitory action is useful for therapy and prevention for example, arrhythmia, various neuralgias and analgesic |
| 08/31/2004 | US6784191 As blood-coagulation inhibitor or an agent for therapy and prophylaxis of thrombosis or embolism, containing |
| 08/31/2004 | US6784189 Potassium channel inhibitors and method |
| 08/31/2004 | US6784187 8-carboxamido-2,6-methano-3-benzazocines |
| 08/31/2004 | US6784179 Tetracyclic derivatives, process of preparation and use |
| 08/31/2004 | US6784175 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments |
| 08/31/2004 | US6784174 Inhibitors of the production of cytokines such as tnf |
| 08/31/2004 | US6784171 Reaction of methyl 2-amino-4-(4-fluorophenyl)-6-isopropyl-pyrimidine-5-carboxylate with methanesulfonyl chloride in the presence of strong base, reaction of the intermediate with a methylating agent in presence of strong base |
| 08/31/2004 | US6784169 Metalloprotease inhibitor; antiinflamamtory agents; rheumatic disorders; cardiovascular disorders; controlling cell proliferation |
| 08/31/2004 | US6784157 Peptide activates dna binding of wild-type p53 or a p53 mutant containing a single amino acid substitution; a peptidomimetic consisting of four sequential amino acids from a negative regulatory region; anticarcinogenic, -tumor agents |
| 08/31/2004 | US6783977 Internal ribosome entry site and vector containing same |
| 08/31/2004 | US6783775 Comprising ceruloplasmin and a serum-derived composition (sdf) having a low molecular weight, electrically charged at acidic ph and having absorption at 280 mn, capable of inducing terminal cell differentiation of leukemic cells |
| 08/31/2004 | CA2194369C Methods and compositions for the specific coagulation of vasculature |
| 08/27/2004 | CA2458001A1 Regulation of immune responses by manipulation of intermediary metabolite levels |
| 08/26/2004 | WO2004072643A2 Diagnostics and therapeutics for diseases associated with glucagon-like peptide 2 receptor (glp2r) |
| 08/26/2004 | WO2004072056A1 Medicinal composition |
| 08/26/2004 | WO2004072040A1 Crystalline forms of pitavastatin calcium |
| 08/26/2004 | WO2004071529A2 Uses of anti-insulin-like growth factor i receptor antibodies |
| 08/26/2004 | WO2004071416A2 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 08/26/2004 | WO2004071395A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor ox1r (ox1r) |
| 08/26/2004 | WO2004071392A2 Diagnostics and therapeutics for diseases associated with acetylcholine receptor, muscarinic 4(m4) |
| 08/26/2004 | WO2004071385A2 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention |
| 08/26/2004 | WO2004071381A2 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds |
| 08/26/2004 | WO2004071378A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
| 08/26/2004 | WO2004056991A3 Novel angiogenic molecular target and uses thereof |
| 08/26/2004 | WO2004014298B1 Composition and method for lowering cholesterol |
| 08/26/2004 | WO2003103585A3 Methods of treating angiogenesis, tumor growth, and metastasis |
| 08/26/2004 | WO2003092602A3 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 08/26/2004 | WO2003088905A3 Compositions and minimally invasive methods for treating incomplete tissue repair |
| 08/26/2004 | WO2003087296A3 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells |
| 08/26/2004 | WO2003055440A3 Compositions and methods for the treatement of immune related diseases |
| 08/26/2004 | WO2001051003A3 Use of lipid conjugates in the treatment of disease |
| 08/26/2004 | US20040167572 Coated medical devices |
| 08/26/2004 | US20040167341 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 08/26/2004 | US20040167335 For therapy and prophylaxis of herpes viral infections |
| 08/26/2004 | US20040167229 lowering C-reactive protein; compounds such as 6,6'-oxybis(2,2-dimethylhexanoic acid) |
| 08/26/2004 | US20040167224 Nitrogen containing heterocyclic compounds and medicines containing the same |
| 08/26/2004 | US20040167216 Carbidopa prodrugs and derivatives, and compositions and uses thereof |
| 08/26/2004 | US20040167201 Pyrrolidine melanocortin-specific compounds |
| 08/26/2004 | US20040167176 Tricyclic compounds useful as angiotensin II agonists |
| 08/26/2004 | US20040167160 Skin disorders; controlling cell differentiation; antidiabetic agents; cardiovascular disorders; anticancer agents; central nervous system disorders |
| 08/26/2004 | US20040167155 Treating atherosclerosis, myocardial infarction, congestive heart failure, inflammatory bowel disease, arthritis, diabetes and autoimmune diseases |
| 08/26/2004 | US20040167150 Treatment methods |
| 08/26/2004 | US20040167149 Aryl fused azapolycyclic compounds |
| 08/26/2004 | US20040167142 Pyrimidinone compounds |
| 08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 08/26/2004 | US20040167138 Antiischemic agents; brain disorders |
| 08/26/2004 | US20040167137 Xanthine phosphodiesterase V inhibitors |
| 08/26/2004 | US20040167133 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/26/2004 | US20040167131 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 08/26/2004 | US20040167118 Novel diarylalkene derivatives and novel diarylalkane derivatives |
| 08/26/2004 | US20040167108 Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease |
| 08/26/2004 | US20040167074 Therapeutic applications of mFLINT polypeptides |
| 08/26/2004 | US20040166565 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 08/26/2004 | DE10306202A1 2-(hetero)aryl-2-(N-((hetero)aryl)-amino)-acetic acid derivatives useful e.g. for treating anxiety, inflammation, allergy, depression, diarrhea or especially pain is NMDA antagonist |
| 08/26/2004 | DE10306179A1 Composition useful for preventing stroke comprises dipyridamole or its salt, acetyl salicylic acid and an angiotensin II antagonist |
| 08/26/2004 | DE10305070A1 Use of sodium-hydrogen ion antiporter 1 inhibitors e.g. N-(4,5-bis-methanesulfonyl-2-methyl-2-methyl-benzoyl)-guanidine, used at doses causing only partial inhibition, e.g. for treating arrhythmia or angina |
| 08/26/2004 | DE10303229A1 α-Liponsäure, Ambroxol und/oder Inhibitoren des Angiotensin Converting-Enzyms (ACE) umfassende Arzneimittel-Zubereitung und ihre Verwendung zur Behandlung von neurodegenerativen Erkrankungen α-lipoic acid, ambroxol and / or inhibitors of the angiotensin converting enzyme (ACE) comprehensive drug preparation and their use for the treatment of neurodegenerative diseases |
| 08/26/2004 | CA2785954A1 Crystalline forms of pitavastatin calcium |
| 08/26/2004 | CA2515941A1 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention |
| 08/26/2004 | CA2515658A1 Medicinal composition |
| 08/26/2004 | CA2514231A1 Uses of anti-insulin-like growth factor i receptor antibodies |
| 08/26/2004 | CA2513837A1 Crystalline forms of pitavastatin calcium |
| 08/25/2004 | EP1449843A1 Intermediates for the preparation of carbamoyl tetrahydropyridine derivatives |
| 08/25/2004 | EP1449545A1 Medical devices comprising rapamycin |
| 08/25/2004 | EP1449539A2 Prophylactic or therapeutic use of a Fas antagonist to inhibit Fas-mediated apoptosis |
| 08/25/2004 | EP1449536A1 Prion proteins (PrP) as therapeutic agents for the treatment of AP-1 associated diseases |
| 08/25/2004 | EP1449529A1 Protein Kinase C Inhibitors |
| 08/25/2004 | EP1448986A2 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 08/25/2004 | EP1448794A2 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis |
| 08/25/2004 | EP1448790A2 Methods and compositions for treating cancer |
| 08/25/2004 | EP1448586A2 Therapeutic methods for nucleic acid delivery vehicles |
| 08/25/2004 | EP1448583A2 A novel g protein-coupled receptor, gave8 |
| 08/25/2004 | EP1448566A2 Chemokine receptor antagonists and methods of use thereof |
| 08/25/2004 | EP1448565A1 ADENOSINE A?2a? RECEPTOR ANTAGONISTS |
| 08/25/2004 | EP1448564A2 Substituted indolizine-like compounds and methods of use |
| 08/25/2004 | EP1448562A1 Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 08/25/2004 | EP1448557A2 Heteroindanes: a new class of potent cannabimimetic ligands |
| 08/25/2004 | EP1448553A1 N-heterocyclyl hydrazides as neurotrophic agents |
| 08/25/2004 | EP1448550A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity |
| 08/25/2004 | EP1448548A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448545A1 Nf-kb inhibitors |
| 08/25/2004 | EP1448544A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 08/25/2004 | EP1448542A1 6-hydroxy isoflavones, derivatives and medicaments involving same |
| 08/25/2004 | EP1448537A2 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses |
| 08/25/2004 | EP1448535A1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 08/25/2004 | EP1448527A1 Method of resolving amlodipine racemate |
| 08/25/2004 | EP1448526A1 Piperidine-based mch antagonists for treatment of obesity and cns disorders |
| 08/25/2004 | EP1448525A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 08/25/2004 | EP1448524A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 08/25/2004 | EP1448523A1 Heterocyclic compounds and methods of use |
| 08/25/2004 | EP1448520A1 Benzamide derivatives, processes for their preparation, and their pharmaceutical use |